Heart Test Laboratories (NASDAQ:HSCS) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Heart Test Laboratories (NASDAQ:HSCS) posted its quarterly earnings results on Monday. The company reported ($2.27) EPS for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.03, Zacks reports. During the same quarter last year, the firm earned ($15.92) earnings per share.

Heart Test Laboratories Stock Performance

Shares of HSCS stock opened at $3.85 on Wednesday. The company has a current ratio of 4.49, a quick ratio of 4.02 and a debt-to-equity ratio of 0.08. Heart Test Laboratories has a 12 month low of $2.36 and a 12 month high of $18.50. The firm has a market capitalization of $3.52 million, a PE ratio of -0.18 and a beta of 3.23. The firm has a fifty day simple moving average of $3.24 and a two-hundred day simple moving average of $3.79.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets reissued a “buy” rating and set a $15.00 price objective on shares of Heart Test Laboratories in a research report on Monday, September 23rd.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.